A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases.
暂无分享,去创建一个
S. Wharton | P. Ince | G. Lace | S. Wharton | S. B. Wharton | Paul G. Ince
[1] A. Grover,et al. Evidence for independent mechanisms and a multiple-hit model of tau assembly. , 2006, Biochemical and biophysical research communications.
[2] J. Trojanowski,et al. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies , 2005, Acta Neuropathologica.
[3] Michael D. Ehlers,et al. Ubiquitin and Protein Turnover in Synapse Function , 2005, Neuron.
[4] F. Liu,et al. Post-translational modifications of tau protein in Alzheimer’s disease , 2005, Journal of Neural Transmission.
[5] F. LaFerla,et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] W. Markesbery,et al. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. , 2005, Journal of Alzheimer's disease : JAD.
[7] M. King. Can tau filaments be both physiologically beneficial and toxic? , 2005, Biochimica et biophysica acta.
[8] G. Hall,et al. Modeling tauopathy: a range of complementary approaches. , 2005, Biochimica et biophysica acta.
[9] Michel Goedert,et al. Mutations causing neurodegenerative tauopathies. , 2005, Biochimica et biophysica acta.
[10] Y. Han,et al. 14-3-3 Protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. , 2004, Molecules and cells.
[11] J. Cho,et al. Glycogen Synthase Kinase 3 (cid:1) Induces Caspase-cleaved Tau Aggregation in Situ * , 2022 .
[12] R. Brandt,et al. Functional interactions of tau and their relevance for Alzheimer's disease. , 2004, Current Alzheimer research.
[13] M. Pericak-Vance,et al. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype , 2004, Neurogenetics.
[14] L. Barbeito,et al. Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. , 2004, In vivo.
[15] Zhijian J. Chen,et al. The novel functions of ubiquitination in signaling. , 2004, Current opinion in cell biology.
[16] E. Kuusisto,et al. Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α‐Synuclein, Ubiquitin, and p62 , 2003, Journal of neuropathology and experimental neurology.
[17] Leslie Wilson,et al. Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] Bin Zhang,et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] Kazuki Sato,et al. Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Roder. Prospect of therapeutic approaches to tauopathies. , 2003 .
[21] J. Wood,et al. Transgenic zebrafish model of neurodegeneration , 2002, Journal of neuroscience research.
[22] I. Grundke‐Iqbal,et al. Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 , 2002, Neuroscience.
[23] S. Yen,et al. Cellular models for tau filament assembly , 2002, Journal of Molecular Neuroscience.
[24] M. Gold. Tau therapeutics for alzheimer’s disease , 2002, Journal of Molecular Neuroscience.
[25] M. Spillantini,et al. Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.
[26] A. Lees,et al. The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies , 2002, FEBS letters.
[27] T. Godenschwege,et al. New Roles for Ubiquitin in the Assembly and Function of Neuronal Circuits , 2002, Neuron.
[28] L. Tsai,et al. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains , 2002, FEBS letters.
[29] I. Ferrer,et al. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration , 2002, Acta Neuropathologica.
[30] D. Dickson,et al. Argyrophilic Grain Disease Is a Sporadic 4‐Repeat Tauopathy , 2002, Journal of neuropathology and experimental neurology.
[31] B. Dubois,et al. Association between the extended tau haplotype and frontotemporal dementia. , 2002, Archives of neurology.
[32] P. Seymour,et al. Tau protein phosphorylation as a therapeutic target in Alzheimer's disease. , 2002, Current topics in medicinal chemistry.
[33] J. Haines,et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. , 2001, JAMA.
[34] Khadija Iqbal,et al. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. , 2001, The Journal of biological chemistry.
[35] M N Rossor,et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype , 2001, Neurology.
[36] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[37] R. Maccioni,et al. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. , 2001, Experimental cell research.
[38] Linda Hicke,et al. Ubiquitin and proteasomes: Protein regulation by monoubiquitin , 2001, Nature Reviews Molecular Cell Biology.
[39] E. Matsubara,et al. Aβ amyloidosis induces the initial stage of tau accumulation in APPSw mice , 2001, Neuroscience Letters.
[40] T. Beach,et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy , 2001, Acta Neuropathologica.
[41] Xiongwei Zhu,et al. Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease , 2001, Journal of neurochemistry.
[42] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[43] R. Crowther,et al. Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.
[44] P. Fraser,et al. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.
[45] H. Braak,et al. Distribution of Active Glycogen Synthase Kinase 3β (GSK-3β) in Brains Staged for Alzheimer Disease Neurofibrillary Changes , 1999 .
[46] M. Hutton,et al. Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations , 1999, FEBS letters.
[47] H. Band,et al. Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.
[48] M. Goedert,et al. Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.
[49] R. Tanzi,et al. Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations , 1998, Cellular and Molecular Life Sciences CMLS.
[50] M. Mercken,et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] A Klug,et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[52] L. Thal,et al. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy , 1998, Neuroscience Letters.
[53] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[54] G. Schellenberg,et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.
[55] H. Akiyama,et al. Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.
[56] I Litvan,et al. The clinical and pathologic hallmarks of progressive supranuclear palsy. , 1997, Current opinion in neurology.
[57] Philip R. Cohen,et al. Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.
[58] U. Wagner,et al. Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. , 1997, The Biochemical journal.
[59] G. Hall,et al. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] Khadija Iqbal,et al. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[61] R. Crowther,et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.
[62] I. Grundke‐Iqbal,et al. Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.
[63] U. Wagner,et al. Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. , 1996, Journal of cell science.
[64] M. Goedert,et al. Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .
[65] T. Arendt,et al. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease , 1995, Neuroscience.
[66] D W Dickson,et al. Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.
[67] R. Kalaria,et al. Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.
[68] M. Goedert,et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.
[69] D. Dickson,et al. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. , 1994, The American journal of pathology.
[70] Y. Ihara,et al. Posttranslational modifications of tau in paired helical filaments. , 1994, Dementia.
[71] I. Grundke‐Iqbal,et al. Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain , 1993, Journal of neurochemistry.
[72] E. Mandelkow,et al. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.
[73] J. Wood,et al. p44mpk MAP kinase induces aizheimer type alterations in tau function and in primary hippocampal neurons , 1993 .
[74] Yasuo Ihara,et al. Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.
[75] K. Kosik,et al. Structure and novel exons of the human tau gene. , 1992, Biochemistry.
[76] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[77] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[78] R. Crowther,et al. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[79] N. Cairns,et al. Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.
[80] P. Mcgeer,et al. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue , 1992, Neuroscience Letters.
[81] A. Delacourte,et al. Abnormal Tau proteins in progressive supranuclear palsy , 1991, Acta Neuropathologica.
[82] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[83] Khadija Iqbal,et al. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease , 1991, Brain Research.
[84] M. Goedert,et al. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.
[85] P. Davies,et al. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[86] H. Braak,et al. CORTICAL AND SUBCORTICAL ARGYROPHILIC GRAINS CHARACTERIZE A DISEASE ASSOCIATED WITH ADULT ONSET DEMENTIA , 1989, Neuropathology and applied neurobiology.
[87] K. Jellinger,et al. Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease , 1989, Brain Research.
[88] S. Love,et al. Alz-50, Ubiquitin and Tau Immunoreactivity of Neurofibrillary Tangles, Pick Bodies and Lewy Bodies , 1988, Journal of neuropathology and experimental neurology.
[89] K. Kosik,et al. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease , 1987, Annals of neurology.
[90] D. Selkoe,et al. Tau Epitopes are Incorporated into a Range of Lesions in Alzheimer's Disease , 1987, Journal of neuropathology and experimental neurology.
[91] H. Wiśniewski,et al. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences , 1987, Acta Neuropathologica.
[92] D. Pollen,et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.
[93] N. Robakis,et al. CHROMOSOME 21q21 SUBLOCALISATION OF GENE ENCODING BETA-AMYLOID PEPTIDE IN CEREBRAL VESSELS AND NEURITIC (SENILE) PLAQUES OF PEOPLE WITH ALZHEIMER DISEASE AND DOWN SYNDROME , 1987, The Lancet.
[94] J. Ávila,et al. Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. , 1986, Biochemical and biophysical research communications.
[95] R. Neve,et al. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.
[96] A. Delacourte,et al. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1986, Journal of the Neurological Sciences.
[97] S. Mirra,et al. FILAMENTOUS AGGREGATES IN PICK'S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND ALZHEIMER'S DISEASE SHARE ANTIGENIC DETERMINANTS WITH MICROTUBULE-ASSOCIATED PROTEIN, TAU , 1986, The Lancet.
[98] J. Brion,et al. ALZHEIMER'S DISEASE AND TAU PROTEINS , 1986, The Lancet.
[99] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[100] S. Mirra,et al. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[101] D. Selkoe,et al. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[102] H. Wiśniewski,et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.
[103] A. Frankfurter,et al. The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.
[104] G. Lindwall,et al. The purification of tau protein and the occurrence of two phosphorylation states of tau in brain. , 1984, The Journal of biological chemistry.
[105] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[106] G. Lindwall,et al. Phosphorylation affects the ability of tau protein to promote microtubule assembly. , 1984, The Journal of biological chemistry.
[107] M. Kirschner,et al. Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes , 1984, The Journal of cell biology.
[108] J. Nunez,et al. Multisite phosphorylation of τ proteins from rat brain , 1983 .
[109] M. Kirschner,et al. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.
[110] M. Kirschner,et al. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.
[111] M. Kirschner,et al. A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[112] P. Mcgeer,et al. Further observations on Tau-positive glia in the brains with progressive supranuclear palsy , 2004, Acta Neuropathologica.
[113] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[114] R. Cuadros,et al. Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. , 2004, Journal of Alzheimer's disease : JAD.
[115] H. Braak,et al. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.
[116] T. Tokuda,et al. Thorn-shaped astrocytes: possibly secondarily induced tau-positive glial fibrillary tangles , 2004, Acta Neuropathologica.
[117] M. Lerman,et al. Isolation, characterization, and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer's disease, Down's syndrome and aging. , 1987, Journal of neural transmission. Supplementum.
[118] J. Delabar,et al. The beta amyloid protein (AD-AP) cDNA hybridizes in normal and Alzheimer individuals near the interface of 21q21 and q22.1. , 1987, Annales de genetique.
[119] Y. Ihara,et al. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. , 1986, Journal of biochemistry.